News
British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...
Additionally, the FDA has granted a Priority Review for Revuforj’s supplemental New Drug Application (sNDA) in relapsed or ...
GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...
Gepotidacin was approved by the FDA earlier this year, under the Blujepa brand, as the first oral antibiotic to offer a new ...
The NDA for the gonorrhea indication is supported by data from the EAGLE-1 study, which compared the safety and efficacy of oral gepotidacin to a standard of care combination.
The FDA has agreed to fast-track its review of gepotidacin, an oral antibiotic already approved for urinary tract infections, ...
1d
GlobalData on MSNGSK’s oral antibiotic for gonorrhoea set for FDA review
A new pill that combats antibiotic-resistant strains of gonorrhoea has inched closer to approval in the US, after the US Food and Drug Administration (FDA) accepted GSK’s gepotidacin for priority ...
GSK (NYSE:GSK) announced on Monday that the U.S. FDA has granted priority review for its marketing application, aimed at ...
US FDA accepts for priority review GSK’s sNDA for gepotidacin for oral treatment of uncomplicated urogenital gonorrhoea: London, UK Tuesday, August 12, 2025, 10:00 Hrs [IST] GSK ...
1d
InvestorsHub on MSNGSK shares rise after FDA grants priority review for oral gonorrhea antibiotic
GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...
Theravance Biopharma, Inc. ( NASDAQ: TBPH) Q2 2025 Earnings Conference Call August 12, 2025 5:00 PM ET Aine Miller - Senior VP of Development & Head of Ireland Office Aziz Sawaf - Senior VP & CFO ...
Going out to eat? See which Marion County restaurants were rated best by inspectors, and which failed the test.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results